Endocrine Factors Affecting Neonatal Growth

Fetal and Neonatal Physiology: Third Edition

Volumn 1-2, Issue , 2003, Pages 266-275

  Styne, Dennis M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845886295     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50031-X     Document Type: Chapter

References (153)

1. Wollmann HA Growth hormone and growth factors during perinatal life. Horm Res 2000, 53(Suppl 1):50.
2. Tanner JM A History of the Study of Human Growth 1981, Cambridge University Press, Cambridge.
3. Karlberg J On the construction of the infancy-childhood-puberty growth standard [see comments]. Acta Paediatr Scandinavica Supplement 1989, 356:26.
4. Karlberg J The infancy-childhood growth spurt. Acta Paediatr Suppl 1990, 367:111.
5. Laron Z The diagnostic and prognostic importance of neonatal length measurements. Isr Med Assoc J 2000, 2:84.
6. Gibson AT, et al. Neonatal and post-natal growth. Horm Res 2000, 53(Suppl 1):42.
7. Cooney K, et al. Infant growth charts. Arch Dis Child 1994, 71:159.
8. Gairdner D, Pearson J A growth chart for premature and other infants. Arch Dis Child 1971, 46:783.
9. Wales JK, et al. The measurement of neonates. Horm Res 1997, 48:2.
10. Johnson TS, et al. Reliability of length measurements in full-term neonates. J Obstetri Gynecol Neonat Nurs 1998, 27:270.
11. Gibson AT, et al. Knemometry and the assessment of growth in premature babies. Arch Dis Child 1993, 69(5 Spec No):498.
12. Kaempf DE, et al. Validation of a newly developed mini-knemometer for premature infants. Ann Hum Biol 1999, 26:259.
13. Greco L, et al. Pulsatile weight increases in very low birthweight babies appropriate for gestational age. Arch Dis Child 1990, 65(4 Spec No):373.
14. Kaempf DE, et al. Influence of nutrition on growth in premature infants: assessment by knemometry. Ann Hum Biol 1998, 25:127.
15. Wales JK, Gibson AT Short-term growth: rhythms, chaos, or noise?. Arch Dis Child 1994, 71:84.
16. Smith DW, et al. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr 1976, 89:225.
17. Williams MC, O'Brien WF Cerebral palsy in infants with asymmetric growth restriction. Am J Perinatol 1999, 14:211.
18. Guo SS, et al. Weight-for-length reference data for preterm, low-birth-weight infants. Arch Pediatr Adolesc Med 1996, 150:964.
19. Guo SS, et al. Growth in weight, recumbent length, and head circumference for preterm low-birthweight infants during the first three years of life using gestation-adjusted ages. Early Hum Dev 1997, 47:305.
20. Gardosi J, et al. Customised antenatal growth charts. Lancet 1992, 339:283.
21. Owen P, et al. Relationship between customised birthweight centiles and neonatal anthropometric features of growth restriction. Br J Obstet Gynecol 2002, 109:658.
22. Cheung YB, et al. Parametric modelling of neonatal mortality in relation to size at birth. Stat Med 2001, 20:2455.
23. Gill A, et al. Postnatal growth in infants born before 30 weeks' gestation. Arch Dis Child 1986, 61:549.
24. Casey PH, et al. Growth patterns of low birth weight preterm infants: a longitudinal analysis of a large, varied sample. J Pediatr 1990, 117:298.
25. Albertsson-Wikland K, Karlberg J Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994, 399:64.
26. Albertsson-Wikland K, et al. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res 1998, 49:7.
27. Karlberg J, Albertsson-Wikland K Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995, 38:733.
28. Fitzhardinge PM, Inwood S Long-term growth in small-for-date children. Acta Paediatr Suppl 1989, 349:27.
29. Seminara S, et al. Catch-up growth in short-at-birth NICU graduates. Horm Res 2000, 53:139.
30. Nieto A, et al. Different postnatal growth between disproportionate and proportionate fetal growth retardation at term. Zentralb Gynakol 1999, 119:633.
31. Fitzhardinge P Follow-up studies on small for dates infants. Curr Concepts Nutr 1985, 14:147.
32. Karlberg J, Albertsson-Wikland K Growth in full-term small-for-gestational-age infants: from birth to final height [published erratum appears in Pediatr Res 39:175, 1996]. Pediatr Res 1995, 38:733.
33. Gutbrod T, et al. Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison. Arch Dis Child Fetal Neonatal Ed 2000, 82:F208.
34. Sung IK, et al. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: comparison with control subjects matched by birth weight and gestational age. J Pediatr 1993, 123:618.
35. Monset-Couchard M, de Bethmann O Catch-up growth in 166 small-for-gestational age premature infants weighing less than 1,000 g at birth. Biol Neonate 2000, 78:161.
36. Strauss RS, Pollack HA Epidemic increase in childhood overweight, 1986-1998. JAMA 2001, 286:2845.
37. Hack M, et al. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002, 346:149.
38. Fewtrell MS, et al. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease?. J Pediatr 2000, 137:668.
39. Fewtrell MS, et al. Bone mineralization and turnover in preterm infants at 8-12 years of age: the effect of early diet. J Bone Miner Res 1999, 14:810.
40. Lewis UJ, et al. Human growth hormone: a complex of proteins. Rec Prog Horm Res 1980, 36:477.
41. Lewis UJ, et al. The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem Biophys Res Commun 1980, 92:511.
42. Miller WL, Eberhardt NL Structure and evolution of the growth hormone gene family. Endocr Rev 1983, 4:97.
43. Thorner MO, et al. Neuroendocrine regulation of growth hormone secretion. Neurosci Biobehav Rev 1995, 19:465.
44. Holl RW, et al. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin. Endocrinology 1988, 122:2927.
45. Reiter EO, Rosenfeld RG Normal and aberrant growth. Williams Textbook of Endocrinology 1998, 1427-1507. WB Saunders, Philadelphia. J.D. Wilson (Ed.).
46. Arvat E, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86:1169.
47. Broglio F, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001, 86:5083.
48. Leung DW, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987, 330:537.
49. Laron Z, Klinger B Laron syndrome: clinical features, molecular pathology and treatment. Horm Res 1994, 42:198.
50. Hintz RL, et al. Somatomedin and growth hormone in the newborn. Am J Dis Child 1977, 131:1249.
51. Keret R, et al. Correlation between plasma growth hormone and insulin and blood glucose concentrations in premature infants. Horm Res 1976, 7:313.
52. Adcock CJ, et al. The use of an automated microsampling system for the characterization of growth hormone pulsatility in newborn babies. Pediatr Res 1997, 42:66.
53. Ogilvy-Stuart AL, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998, 83:3550.
54. de Zegher F, et al. Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. J Clin Endocrinol Metab 1993, 76:1177.
55. Miller JD, et al. Spontaneous growth hormone release in term infants: changes during the first four days of life. J Clin Endocrinol Metab 1993, 76:1058.
56. Miller JD, et al. Spontaneous pulsatile growth hormone release in male and female premature infants. J Clin Endocrinol Metab 1992, 75:1508.
57. Deiber M, et al. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab 1989, 68:232.
58. Hikino S, et al. Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH. Pediatr Res 2001, 50:732.
59. Wright NM, et al. Elevated growth hormone secretory rate in premature infants: deconvolution analysis of pulsatile growth hormone secretion in the neonate. Pediatr Res 1992, 32:286.
60. Leger J, et al. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR. Pediatr Res 1996, 40:101.
61. Bozzola M, et al. Postnatal variations of growth hormone bioactivity and of growth hormone-dependent factors. Arch Pediatr Adolesc Med 1996, 150:1068.
62. Quattrin T, et al. Comparison of urinary growth hormone and IGF-I excretion in small- and appropriate-for-gestational-age infants and healthy children. Pediatr Res 1990, 28:209.
63. Low LC, et al. Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life. Pediatr Res 2001, 50:737.
64. Huet F, et al. Long-term results of GH therapy in GH-deficient children treated before 1 year of age. Eur J Endocrinol 1999, 140:29.
65. Parks JS Hormones of the pituitary and hypothalamus. Nelson's Textbook of Pediatrics 2002, 1673-1680. WB Saunders, Philadelphia. R.E. Behrman (Ed.).
66. Parks JS Genetic forms of hypopitutarism. Saunders Manual of Pediatric Practice 2002, WB Saunders, Philadelphia. L. Finberg (Ed.).
67. Laron Z The essential role of IGF-1: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 1999, 84:4397.
68. Woods KA, et al. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997, 423:39.
69. Woods KA, et al. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997, 423:39.
70. Rinderknecht E, Humbel RE The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978, 253:2769.
71. Rinderknecht E, Humbel RE Primary structure of human insulin-like growth factor II. FEBS Lett 1978, 89:283.
72. Sussenbach JS The gene structure of the insulin-like growth factor family. Prog Growth Factor Res 1989, 1:33.
73. Underwood LE, et al. Paracrine functions of somatomedins. Clin Endocrinol Metab 1986, 15:59.
74. Clemmons DR, et al. Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle. Proc Natl Acad Sci U S A 1980, 77:6644.
75. Massague J, Czech MP The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982, 257:5038.
76. Ullrich A, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985, 313:756.
77. Rosenfeld RG, et al. Insulinlike growth factor-binding proteins. Rec Prog Horm Res 1990, 46:99.
78. Ong K, et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 2000, 85:4266.
79. Hill DJ, et al. Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. J Clin Endocrinol Metab 1992, 75:646.
80. Heinrich UE, et al. NSILA and foetal growth. Acta Endocrinol (Copenh) 1979, 90:534.
81. Radetti G, et al. Growth hormone bioactivity and levels of growth hormone, growth hormone-binding protein, insulinlike growth factor I, and insulinlike growth factor-binding proteins in premature and full-term newborns during the first month of life. Arch Pediatr Adolesc Med 1997, 151:170.
82. Cance-Rouzaud A, et al. Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates. Biol Neonate 1998, 73:347.
83. Wiznitzer A, et al. Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998, 15:23.
84. Vatten LJ, et al. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight. Obstet Gynecol 2002, 99:85.
85. Hills FA, et al. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996, 148:303.
86. Wang HS, et al. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 1991, 129:459.
87. Barrios V, et al. Insulin-like growth factor I, insulin-like growth factor binding proteins, and growth hormone binding protein in Spanish premature and full-term newborns. Horm Res 1996, 46:130.
88. Giudice LC, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995, 80:1548.
89. Bernardini S, et al. Plasma levels of insulin-like growth factor binding protein-1, and growth hormone binding protein activity from birth to the third month of life. Acta Endocrinol (Copenh) 1992, 127:313.
90. Orbak Z, et al. Maternal and fetal serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), leptin levels and early postnatal growth in infants born asymmetrically small for gestational age. J Pediatr Endocrinol Metab 2001, 14:1119.
91. Ozkan H, et al. Associations of IGF-I, IGFBP-1 and IGFBP-3 on intrauterine growth and early catch-up growth. Biol Neonate 1999, 76:274.
92. Thieriot-Prevost G, et al. Serum insulin-like growth factor 1 and serum growth-promoting activity during the first postnatal year in infants with intrauterine growth retardation. Pediatr Res 1988, 24:380.
93. Cianfarani S, et al. Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life. Pediatr Res 1998, 44:374.
94. Garcia H, et al. GH-IGF axis during catch up growth in small for gestational age (SGA) infants. J Pediatr Endocrinol Metab 1996, 9:561.
95. Colonna F, et al. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) in growing preterm infants on enteral nutrition. J Pediatr Endocrinol Metab 1996, 9:483.
96. Iwashita M, et al. Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 1998, 8:487.
97. Kajantie E, et al. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab 2002, 87:2171.
98. D'Ercole AJ, et al. Use of transgenic mice for understanding the physiology of insulin-like growth factors. Horm Res 1996, 45(Suppl 1):5.
99. D'Ercole AJ Insulin-like growth factors and their receptors in growth. Endocrinol Metab Clin North Am 1996, 25:573.
100. Baker J Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73.
101. Liu JP, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1r). Cell 1993, 75:59.
102. Gluckman PD, et al. Elevating maternal insulin-like growth factor-I in mice and rats alters the pattern of fetal growth by removing maternal constraint. J Endocrinol 1992, 134:R1.
103. Filson AJ, et al. Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 1993, 118:731.
104. Ludwig T, et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in IGF2 and IGF1r null backgrounds. Dev Biol 1996, 177:517.
105. Murphy LJ, et al. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog Growth Factor Res 1995, 6:425.
106. Rajkumar K, et al. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 in transgenic mice. Endocrinology 1995, 136:4029.
107. Murphy LJ, et al. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 1995, 15:293.
108. Tarantal AF, Gargosky SE Characterization of the insulin-like growth factor I. Growth Reg 1995, 5:190.
109. Fowden AL The role of insulin in prenatal growth. J Dev Physiol 1989, 12:173.
110. Economides DL, et al. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 1991, 19:97.
111. Vohr BR, McGarvey ST Growth patterns of large-for-gestational-age and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year. Diabetes Care 1997, 20:1066.
112. Fukuzawa R, et al. Nesidioblastosis and mixed hamartoma of the liver in Beckwith-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting. Pediatr Dev Pathol 2001, 4:381.
113. Donohue W, Uchida I Leprechaunism: a euphemism for a rare familial disorder. J Pediatr 1954, 45:505.
114. Bier DM, et al. Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance. J Clin Endocrinol Metab 1980, 51:988.
115. Tamemoto H, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994, 372:182.
116. Ogilvy-Stuart AL, et al. Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors. J Clin Endocrinol Metab 2001, 86:3319.
117. Dodge JA, Laurence KM Congenital absence of islets of Langerhans. Arch Dis Child 1977, 52:411.
118. Chan JL, et al. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002, 51:2105.
119. Sivan E, et al. Leptin is present in human cord blood. Diabetes 1997, 46:917.
120. Matsuda J, et al. Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 1999, 82:1642.
121. Schubring C, et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997, 82:1480.
122. Jaquet D, et al. Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab 1998, 83:1243.
123. Christou H, et al. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001, 86:935.
124. Jaquet D, et al. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab 1999, 84:1949.
125. LaFranchi S Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999, 9:735.
126. Heyerdahl S, et al. Linear growth in early treated children with congenital hypothyroidism. Acta Paediatr 1999, 86:479.
127. Leger J, Czernichow P Congenital hypothyroidism: decreased growth velocity in the first weeks of life. Biol Neonate 1989, 55:218.
128. Cassio A, et al. Low growth hormone-binding protein in infants with congenital hypothyroidism. J Clin Endocrinol Metab 1998, 83:3643.
129. Mitchell ML, et al. Somatomedin-C/insulin-like growth factor-1 in infants with congenital hypothyroidism during the first week of life. Clin Endocrinol (Oxf) 1987, 27:625.
130. Kandemir N, et al. Age-related differences in serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in congenital hypothyroidism. J Pediatr Endocrinol Metab 1997, 10:379.
131. Bona G, et al. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment. Minerva Endocrinol 1999, 24:51.
132. Virtanen M, Perheentupa J Bone age at birth; method and effect of hypothyroidism. Acta Paediatr Scand 1989, 78:412.
133. Casado dF, et al. Evolution of height and bone age in primary congenital hypothyroidism. Clin Pediatr 1993, 32:426.
134. Grant DB Growth in early treated congenital hypothyroidism. Arch Dis Child 1994, 70:464.
135. Siragusa V, et al. Congenital hypothyroidism: auxological retrospective study during the first six years of age. J Endocrinol Invest 1996, 19:224.
136. Fisher DA Catch-up growth in hypothyroidism. N Engl J Med 1988, 318:632.
137. Chiesa A, et al. Growth follow-up in 100 children with congenital hypothyroidism before and during treatment. J Pediatr Endocrinol 1994, 7:211.
138. Aronson R, et al. Growth in children with congenital hypothyroidism detected by neonatal screening. J Pediatr 1990, 116:33.
139. Salerno M, et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001, 145:377.
140. Dickerman Z, De Vries L Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH- a longitudinal study [see comments]. Clin Endocrinol 1997, 47:649.
141. Salerno M, et al. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002, 12:45.
142. Hrytsiuk I, et al. Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review. Arch Pediatr Adolesc Med 2002, 156:485.
143. Dubuis JM, et al. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996, 81:222.
144. Bongers-Schokking JJ, et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000, 136:292.
145. Fisher DA, Foley BL Early treatment of congenital hypothyroidism. Pediatrics 1989, 83:785.
146. American Academy of Pediatrics AAP Section on Endocrinology and Committee on Genetics, and American Thyroid Association Committee on Public Health Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993, 91:1203.
147. Daneman D, Howard NJ Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr 1980, 97:257.
148. Zimmerman D Fetal and neonatal hyperthyroidism. Thyroid 1999, 9:727.
149. Krude H, et al. Congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 1997, 105(Suppl 4):6.
150. Grumbach MM, Styne DM Puberty, ontogeny, neuroendocrinology, physiology, and disorders. Williams Textbook of Endocrinology 1998, 1509-1625. WB Saunders, Philadelphia. J.D. Wilson (Ed.).
151. Styne DM Growth. Basic and Clinical Endocrinology 2001, 163-200. Lange, New York. F.S. Greenspan, D.G. Gardner (Eds.).
152. Cianfarani S, et al. IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. Eur J Endocrinol 1998, 138:524.
153. Cianfarani S, et al. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?. Pediatr Res 2002, 51:94.